Image of Dr. Mark Applebaum, MD, walking the hallway and talking to a pediatric cancer patient, Ari Volchenboum.

What is Pediatric Osteosarcoma?

Osteosarcoma (also known as osteogenic sarcoma) is a tumor that is most often seen in children and almost always occurs in a bone, most commonly near the growth plates around the knee, arms, legs and pelvis. It is the most common type of pediatric bone tumor. Osteosarcoma occurs more frequently in males than in females and usually affects adolescents and young adults between the ages of 10 and 25. Like all sarcomas, the tumor is highly malignant and can metastasize (spread) rapidly to other bones and to the lungs. Accurate diagnosis and staging, and prompt, carefully orchestrated therapy are particularly critical when treating osteosarcoma.

Why Choose UChicago Medicine Comer Children's Hospital for Osteosarcoma?

The University of Chicago Medicine Comer Children’s Hospital has a multidisciplinary team of experts with the experience and advanced resources to diagnose, analyze and treat osteosarcoma and other less common types of bone sarcomas. Pediatric oncologists, radiation oncologists, orthopaedic surgeons, pathologists, nurse specialists and others at Comer Children’s work together as a team to strive for the best results for children with bone sarcomas.

Symptoms of Osteosarcoma

The most common symptoms of osteosarcoma are:

  • Sharp or dull pain at the site of the tumor
  • Swelling and/or redness at the site of the tumor
  • Increased pain with activity or lifting
  • Limping
  • Decreased movement of the affected limb

Pain and swelling in arms and legs are not uncommon in teens and young adults, especially young athletes. When the pain and/or swelling persists, gets worse at night or during exercise, or begins to interfere with activity, a doctor should be consulted.

Diagnosing Osteosarcoma

Getting the correct diagnosis is critical, but isn’t always simple. Multilevel, advanced diagnostics are necessary to detect, locate, identify and stage osteosarcoma. Once a tumor is suspected, your care team will perform state-of-the art imaging studies and procedures including:

  • X-ray to confirm the presence of a tumor
  • Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scan to determine the extent of the tumor
  • Bone scan to identify any additional sites of bone involvement
  • Positron Emission Tomography (PET) scan to find small tumors or check if treatment is working effectively
  • Biopsy to remove tissue from the tumor for microscopic examination by an expert pathologist

Using extensive, specialized testing of the tissue, the pathologist is able to confirm the diagnosis and identify the type of sarcoma. The sarcoma team then assigns a stage to the tumor, defining whether the tumor is localized to only one site or has spread to other sites. Having the correct diagnosis and stage assignment is critical for optimal treatment planning.

Treating Osteosarcoma

There are several steps in the treatment of osteosarcoma. Most patients with osteosarcoma need to be treated with chemotherapy first. Even if the cancer appears to be localized to one place, we know that microscopic amounts of osteosarcoma cells may have spread around the body but are not detectable. Second, effective osteosarcoma therapy nearly always includes surgery to remove all visible tumor. Usually, our osteosarcoma team uses chemotherapy to shrink the tumor before surgery. This is done to have a better chance of removing the tumor without significantly interfering with function or needing an amputation.

Chemotherapy is often used again after surgery to destroy any remaining cancer cells where the primary tumor had been and in other sites as mentioned above. If complete removal of the tumor is not possible or if we can still detect cancer in the tissue surrounding the tumor site after the surgery, radiation may also be necessary. At Comer Children's, we have the capability to provide all of these treatment options on-site, which enables the team to effectively coordinate each child's care and to readily modify treatment plans as the cancer responds to therapy.

Some patients may be eligible for studies of the very newest therapies through clinical trials being conducted at Comer Children's. Parents are closely involved in deciding whether or not to enroll their child in a clinical trial. Clinical trials are only considered by the sarcoma team if they are thought to provide the best chance to cure the osteosarcoma.

Frequently Asked Questions About Osteosarcoma

Our Pediatric Cancer Locations in Chicago and Merrillville

Request an Appointment

The information you provide on this secure form to request an appointment with a Comer pediatric cancer expert will enable us to assist you as efficiently as possible. A representative will contact you within one to two business days to help you schedule an appointment. 

To speak to someone directly, please call 773-702-6169. If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

For Referring Physicians

To refer a pediatric patient for cancer care, please call UCM Physician Connect at 1-800-824-2282

 

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.